|
|
|
 |
|
 |
Press Releases
| |
|
| |
|
| |
Kamada begins Phase I clinical trials for aerosolized API treatment for Congenital Emphysema
November 21, 2006
Joint clinical Development Agreement signed with PARI
Weizmann Science Park, Ness Ziona, Israel, November 21, 2006 Kamada (TASE: KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of prescription medicines, an...
Click here to read the full Press Release
| | | | | |
|
|
|
|
|
|
More
|
|
